AbbVie is a biotech company focusing on the discovery and development of innovative medicines. The likes of which aim to impact a wide array of therapeutic areas across AbbVie's portfolio. These include but are not limited to the fields of immunology, oncology, virology, neuroscience, and eye care. Across its current portfolio, AbbVie currently markets and distributes over 32 drugs in the U.S. Given the scale and variety of AbbVie's work, ABBV stock could be a go-to for biotech investors today.
AbbVie currently has a dividend yield of 4.5%. The company has been gathering a lot of investor's attention recently as the company continues to make tremendous breakthroughs. For the uninitiated, AbbVie recently revealed that its treatment for ulcerative colitis, upadacitinib, met all of its primary and secondary endpoints set in a one-year-long Phase 3 study. According to AbbVie vice-chairman Michael Severino, the results demonstrate the drug's potential as a treatment option for patients with moderate to severe ulcerative colitis. As AbbVie continues to expand its offerings, would you consider adding ABBV stock to your watchlist?
With oil prices briefly hitting a six-year high after OPEC fails to get a deal, things may be looking up for energy stocks like Chevron Corporation. Many investors, including Warren Buffett, love CVX stock because it has a strong balance sheet and good growth prospects. Although the energy sector isn't in its heyday anymore, Chevron has got a few tricks up its sleeves. The company is also keeping up with the times through its initiatives in hydrogen to support the green economy.
The oil giant currently has an attractive dividend yield of 5.17% and its most recent hike was announced earlier this month. The company's credibility as a top dividend stock lies in the track record of its payout. It has increased its payout for the past 34 consecutive years. Chevron is one option to consider if you are looking for a relatively low-risk investment in the energy sector. With one of the strongest balance sheets among its industry peers, investors may feel safer investing in it. After all, the oil and gas sector isn't the shiniest investment you can get in the stock market today . Considering its diversified businesses and a reasonable valuation, would you invest in CVX stock?
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.